Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001012975-15-000048
Filing Date
2015-01-16
Accepted
2015-01-16 16:50:40
Documents
1
Period of Report
2015-01-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6057
  Complete submission text file 0001012975-15-000048.txt   7253
Mailing Address
Business Address
NELSEN ROBERT (Reporting) CIK: 0001219042 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36544 | Film No.: 15533167

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations